home / stock / wald / wald news


WALD News and Press, Waldencast Acquisition Corp. From 03/20/24

Stock Information

Company Name: Waldencast Acquisition Corp.
Stock Symbol: WALD
Market: NASDAQ
Website: waldencast.com

Menu

WALD WALD Quote WALD Short WALD News WALD Articles WALD Message Board
Get WALD Alerts

News, Short Squeeze, Breakout and More Instantly...

WALD - Waldencast Reports First Half 2023 Results

—  H1’23 Total Net Revenue of $109.3 million —  H1’23 Combined Adjusted EBITDA of $13.9 million up from $7.6 million in H1’22 —  Introduces guidance WHITE PLAINS, N.Y., March 20, 2024 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD...

WALD - Obagi Cosmeceuticals Announces the Launch of Daily Hydro-Drops® Rejuvenating Eye Gel Cream

LONG BEACH, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation and the originator of medical-grade skincare and a subsidiary of Waldencast plc, (NASDAQ: WALD) (“Waldencast”), today announced the launch of Dail...

WALD - Waldencast Receives Positive Nasdaq Listing Determination

NEW YORK, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced that by decision dated February 22, 2024, a Nasdaq Hearings Panel (the “Panel”) granted Waldencast’s req...

WALD - Dr. Suzan Obagi Appointed as Chief Medical Director at Obagi Cosmeceuticals, a Subsidiary of Waldencast plc.

LONG BEACH, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Obagi Cosmeceuticals LLC (“Obagi”), a leader in skincare innovation and the originator of medical-grade skincare, is thrilled to announce the appointment of Dr. Suzan Obagi as the Company’s first-ever Chief Medical Directo...

WALD - Waldencast plc (WALD, WALDW) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

NEW YORK, NY / ACCESSWIRE / February 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Waldencast plc ("Waldencast" or "the Company") (NASDAQ:WALD, WALDW). Investors who purchased Waldencast securities are encouraged to obtain addition...

WALD - Waldencast's (WALD) CFO/COO Gautier Abruptly Exits Amid SEC's Investigation into Company's Improper Accounting - Hagens Berman

SAN FRANCISCO, Feb. 09, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Waldencast plc (NASDAQ: WALD) investors who suffered substantial losses to submit your losses now . Waldencast plc (NASDAQ: WALD) Investigation: On Jan. 31, 2024, Waldencast announced that Philippe Gaut...

WALD - Waldencast Announces Participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit

NEW YORK, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced its participation in the TD Cowen Glowing Ahead: Beauty & Wellness Summit being held on February 13, 2024 in New York Cit...

WALD - Waldencast names Manuel Manfredi as CFO

2024-01-31 17:16:33 ET More on Waldencast Waldencast announces receipt of anticipated Nasdaq delinquency notice Waldencast announces receipt of Nasdaq listing stay Seeking Alpha’s Quant Rating on Waldencast Historical earnings data for Waldencast ...

WALD - Waldencast Names Manuel Manfredi as Chief Financial Officer

NEW YORK, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast” or “the Company”), a global multi-brand beauty and wellness platform, announced today that Manuel Manfredi will join the Company as Chief Financial Officer on April 1, 2024. Philip...

WALD - Outperform Recommendation Issued On WALD By Telsey Advisory

2024-01-17 08:00:01 ET Telsey Advisory analyst issues OUTPERFORM recommendation for WALD on January 17, 2024 08:19AM ET. The previous analyst recommendation was Outperform. WALD was trading at $8.7 at issue of the analyst recommendation. The overall analyst consensus : B...

Previous 10 Next 10